Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
Public ClinicalTrials.gov record NCT02013791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Study identification
- NCT ID
- NCT02013791
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Cyclosporine New Ophthalmic Formulation Drug
- Sham Other
- Vehicle Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2014
- Primary completion
- Apr 11, 2017
- Completion
- Apr 11, 2017
- Last update posted
- May 14, 2018
2014 – 2017
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sall Research Medical Center | Artesia | California | 90701 | — |
| Lugene Eye Institute | Glendale | California | 91204 | — |
| Lakeside Vision Center | Irvine | California | 92604 | — |
| Steve Yoelin MD Medical Asscociates | Newport Beach | California | 92663 | — |
| Wolstan & Goldberg Eye Associates | Torrance | California | 90505 | — |
| Vision Institute | Colorado Springs | Colorado | 80907 | — |
| Johns Hopkins University - Wilmer Eye Institute | Baltimore | Maryland | 21287 | — |
| Eye Centers of Racine and Kenosha | Kenosha | Wisconsin | 53142 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02013791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2018 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02013791 live on ClinicalTrials.gov.